Scientists Discover a Surprising Link Between Obesity and Dementia Survival
Obesity is associated with lower risk of death in dementia
Building effective multimodal care for obesity and comorbidities in the GLP-1 therapy era
New investigational drug combining eloralintide and tirzepatide (EloraTZP) led to weight loss of up to 23.3% in people living with obesity and type 2 diabetes
New triple agonist retatrutide produces substantial weight loss and improvements in blood sugar control in people living with obesity and type 2 diabetes – TRIUMPH-2 study
GLP-1 receptor agonist coverage for obesity in Medicaid and total GLP-1 receptor agonist utilization
Effects of obesity decoded
Should we use GLP-1 drugs to treat obesity in children?
Time-restricted eating provides modest weight loss benefits for adults with obesity and prediabetes
Obesity may remove a natural defense against breast cancer
Obesity may remove a natural defense against breast cancer
One of America's Most Widely Consumed Ingredients Linked to Metabolic Changes And Obesity
GLP-1 use among young children with obesity in US remains rare but is rising rapidly
Obesity leaves a lasting memory in immune cells
It's Not Just Calories: How Fructose May Be Quietly Driving Weight Gain
Our Fat Tissue May 'Remember' Obesity, Even After We've Lost Weight
Obesity and cardiovascular diseases
GLP-1 meds prompt rethink of obesity and eating disorder care
GLP-1 meds prompt rethink of obesity and eating disorder care
Researchers Revive Decades-Old Drug to Fight Obesity
